Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.6674 (-9.81%) ($0.6674 - $0.6674) on Sun. Feb. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.27% (three month average) | RSI | 35 | Latest Price | $0.6674(-9.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.9% a day on average for past five trading days. | Weekly Trend | ANPC declines -6.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ANPC price | ANPC will decline at least -3.135% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.135% (StdDev 6.27%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.8 | 5 Day Moving Average | $0.74(-9.81%) | 10 Day Moving Average | $0.8(-16.58%) | 20 Day Moving Average | $0.8(-16.58%) | To recent high | -60.7% | To recent low | 0% | Market Cap | $N/A | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |